132 related articles for article (PubMed ID: 8000055)
41. Color Doppler sonography patterns related to histological findings in Graves' disease.
Morosini PP; Simonella G; Mancini V; Argalia G; Lucarelli F; Montironi R; Diamanti L; Suraci V
Thyroid; 1998 Jul; 8(7):577-82. PubMed ID: 9709910
[TBL] [Abstract][Full Text] [Related]
42. Superior thyroid artery mean peak systolic velocity for the diagnosis of thyrotoxicosis in Japanese patients.
Uchida T; Takeno K; Goto M; Kanno R; Kubo S; Takahashi S; Azuma K; Sakai K; Fujitani Y; Hirose T; Kawamori R; Watada H
Endocr J; 2010; 57(5):439-43. PubMed ID: 20513982
[TBL] [Abstract][Full Text] [Related]
43. Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis.
Iitaka M; Miura S; Yamanaka K; Kawasaki S; Kitahama S; Kawakami Y; Kakinuma S; Oosuga I; Wada S; Katayama S
J Clin Endocrinol Metab; 1998 Nov; 83(11):3908-12. PubMed ID: 9814467
[TBL] [Abstract][Full Text] [Related]
44. Color Doppler imaging of the superior ophthalmic vein in patients with Graves' orbitopathy before and after treatment of congestive disease.
Monteiro ML; Moritz RB; Angotti Neto H; Benabou JE
Clinics (Sao Paulo); 2011; 66(8):1329-34. PubMed ID: 21915479
[TBL] [Abstract][Full Text] [Related]
45. Hypervascularity of nontoxic goiter as shown by color-coded Doppler sonography.
Barreda R; Kaude JV; Fagien M; Drane WE
AJR Am J Roentgenol; 1991 Jan; 156(1):199. PubMed ID: 1772472
[No Abstract] [Full Text] [Related]
46. Mean peak systolic velocity of superior thyroid artery for the differential diagnosis of thyrotoxicosis: a diagnostic meta-analysis.
Peng X; Wu S; Bie C; Tang H; Xiong Z; Tang S
BMC Endocr Disord; 2019 Jun; 19(1):56. PubMed ID: 31170960
[TBL] [Abstract][Full Text] [Related]
47. Color flow Doppler sonography for the etiologic diagnosis of hyperthyroidism.
Erdoğan MF; Anil C; Cesur M; Başkal N; Erdoğan G
Thyroid; 2007 Mar; 17(3):223-8. PubMed ID: 17381355
[TBL] [Abstract][Full Text] [Related]
48. Scintigraphic findings of the thyroid in euthyroid ophthalmic Graves' disease.
Kasagi K; Hidaka A; Misaki T; Miyamoto S; Takeuchi R; Sakahara H; Sasayama S; Iida Y; Konishi J
J Nucl Med; 1994 May; 35(5):811-7. PubMed ID: 8176463
[TBL] [Abstract][Full Text] [Related]
49. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.
Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M
J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of thyrotoxicosis during pregnancy with color flow Doppler sonography.
Hari Kumar KV; Vamsikrishna P; Verma A; Muthukrishnan J; Meena U; Modi KD
Int J Gynaecol Obstet; 2008 Aug; 102(2):152-5. PubMed ID: 18456267
[TBL] [Abstract][Full Text] [Related]
51. [Doppler color ultrasonography in the diagnosis of diffuse hyperthyroidism].
Argalia G; Mignosi U; Lucarelli F; Morosini PP; Aglieri V; Giuseppetti GM
Radiol Med; 1997; 93(1-2):61-6. PubMed ID: 9380870
[TBL] [Abstract][Full Text] [Related]
52. Characteristics of patients with graves disease and intrathyroid hypovascularity compared to painless thyroiditis.
Uchida T; Shigihara N; Takeno K; Komiya K; Goto H; Abe H; Sato J; Honda A; Fujitani Y; Watada H
J Ultrasound Med; 2014 Oct; 33(10):1791-6. PubMed ID: 25253825
[TBL] [Abstract][Full Text] [Related]
53. Natural killer cell activity in patients with Graves' disease and Hashimoto's thyroiditis.
Wenzel BE; Chow A; Baur R; Schleusener H; Wall JR
Thyroid; 1998 Nov; 8(11):1019-22. PubMed ID: 9848716
[TBL] [Abstract][Full Text] [Related]
54. [B-mode ultrasound and modern Doppler ultrasound methods in diseases of the thyroid gland and parathyroid glands].
Saleh A; Santen R; Malms J; Feldkamp J; Fürst G; Scherbaum WA; Mödder U
Radiologe; 1998 May; 38(5):344-54. PubMed ID: 9646340
[TBL] [Abstract][Full Text] [Related]
55. A meta-analysis: elucidating diagnostic thresholds of peak systolic flow velocities in thyroid arteries for the discrimination of Graves' disease and destructive thyrotoxicosis.
Li S; Ding Z; Li X; Fu M; Sang L; Yang M; Tang R; Gu T; Sang L
Front Endocrinol (Lausanne); 2024; 15():1393126. PubMed ID: 38911037
[TBL] [Abstract][Full Text] [Related]
56. Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves' patients.
Wiebolt J; Achterbergh R; den Boer A; van der Leij S; Marsch E; Suelmann B; de Vries R; van Haeften TW
Eur J Endocrinol; 2011 May; 164(5):789-94. PubMed ID: 21378091
[TBL] [Abstract][Full Text] [Related]
57. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
Chan JY; Walfish PG
Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
[TBL] [Abstract][Full Text] [Related]
58. Immunoglobulins from Graves' patients stimulate phospholipase-A2 in FRTL5 thyroid cells.
Di Cerbo A; Di Girolamo M; Guardabasso V; De Filippis V; Corda D
J Clin Endocrinol Metab; 1992 Mar; 74(3):585-92. PubMed ID: 1310998
[TBL] [Abstract][Full Text] [Related]
59. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry.
Chan JY; Walfish PG
J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483
[TBL] [Abstract][Full Text] [Related]
60. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
Yuan S; Yu N; Gao Y; Huang W; He Y; Dong B; Lu G; Li M; Cai X; Peng D; Wang Y; Li T; Huang Y; Gao Y; Guo X; Shi B
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):110-4. PubMed ID: 24721350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
